PER 4.76% 10.0¢ percheron therapeutics limited

Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial, page-23

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,618 Posts.
    lightbulb Created with Sketch. 783


    https://www.livewiremarkets.com/wires/6-pharma-and-biotech-companies-with-strong-momentum


    Crazy how one company is surging with MS and Alzheimers treatment ..

    Didn't read too well but it does looks like some Pharmas have turned the corner...

    IMU hammered under 10c was a shocker....even though they have the capital...so for ANP to stay above 6 C is a bonus....

    Trading looks good today with decent volume on the upside.. have a feeling we will have a series of news coming...

    Dyor

    IMO ..
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
10.0¢
Change
-0.005(4.76%)
Mkt cap ! $90.15M
Open High Low Value Volume
11.0¢ 11.0¢ 10.0¢ $54.97K 528.8K

Buyers (Bids)

No. Vol. Price($)
9 396468 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 99708 1
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.